ALDX
Price
$4.85
Change
-$0.01 (-0.21%)
Updated
Dec 20, 04:59 PM (EDT)
75 days until earnings call
MTNB
Price
$0.55
Change
-$0.02 (-3.51%)
Updated
Dec 20 closing price
Ad is loading...

ALDX vs MTNB

Header iconALDX vs MTNB Comparison
Open Charts ALDX vs MTNBBanner chart's image
Aldeyra Therapeutics
Price$4.85
Change-$0.01 (-0.21%)
Volume$20.05K
CapitalizationN/A
Matinas Biopharma Holdings
Price$0.55
Change-$0.02 (-3.51%)
Volume$63.49K
CapitalizationN/A
ALDX vs MTNB Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. MTNB commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and MTNB is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (ALDX: $4.86 vs. MTNB: $0.55)
Brand notoriety: ALDX and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 90% vs. MTNB: 22%
Market capitalization -- ALDX: $289.41M vs. MTNB: $2.77M
ALDX [@Biotechnology] is valued at $289.41M. MTNB’s [@Biotechnology] market capitalization is $2.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileMTNB’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • MTNB’s FA Score: 1 green, 4 red.
According to our system of comparison, ALDX is a better buy in the long-term than MTNB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while MTNB’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 5 bearish.
  • MTNB’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MTNB is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -0.82% price change this week, while MTNB (@Biotechnology) price change was -4.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ALDX is expected to report earnings on Mar 06, 2025.

MTNB is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($289M) has a higher market cap than MTNB($2.77M). ALDX YTD gains are higher at: 38.462 vs. MTNB (-94.958). MTNB has higher annual earnings (EBITDA): -21.05M vs. ALDX (-42.57M). ALDX has more cash in the bank: 113M vs. MTNB (10.8M). MTNB has less debt than ALDX: MTNB (3.07M) vs ALDX (15.6M). ALDX (0) and MTNB (0) have equivalent revenues.
ALDXMTNBALDX / MTNB
Capitalization289M2.77M10,426%
EBITDA-42.57M-21.05M202%
Gain YTD38.462-94.958-41%
P/E RatioN/AN/A-
Revenue00-
Total Cash113M10.8M1,046%
Total Debt15.6M3.07M508%
FUNDAMENTALS RATINGS
ALDX vs MTNB: Fundamental Ratings
ALDX
MTNB
OUTLOOK RATING
1..100
1355
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
4666
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (20) in the Biotechnology industry is in the same range as ALDX (42). This means that MTNB’s stock grew similarly to ALDX’s over the last 12 months.

MTNB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALDX (100). This means that MTNB’s stock grew similarly to ALDX’s over the last 12 months.

ALDX's SMR Rating (97) in the Biotechnology industry is in the same range as MTNB (98). This means that ALDX’s stock grew similarly to MTNB’s over the last 12 months.

ALDX's Price Growth Rating (46) in the Biotechnology industry is in the same range as MTNB (66). This means that ALDX’s stock grew similarly to MTNB’s over the last 12 months.

ALDX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MTNB (100). This means that ALDX’s stock grew similarly to MTNB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXMTNB
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROKU80.592.16
+2.75%
Roku
VOXR2.330.06
+2.64%
Vox Royalty Corp
FOXF29.870.19
+0.64%
Fox Factory Holding Corp
EQBK42.32-0.04
-0.09%
Equity Bancshares
REVB0.30-0.01
-3.15%
Revelation Biosciences

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
N/A
CANF - ALDX
46%
Loosely correlated
+2.78%
FOLD - ALDX
46%
Loosely correlated
+0.72%
BBIO - ALDX
42%
Loosely correlated
+1.09%
CRNX - ALDX
42%
Loosely correlated
+1.44%
ATAI - ALDX
42%
Loosely correlated
N/A
More

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with REGN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then REGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-3.81%
REGN - MTNB
43%
Loosely correlated
-0.90%
ABCZF - MTNB
37%
Loosely correlated
N/A
SPRC - MTNB
35%
Loosely correlated
-0.19%
AXON - MTNB
34%
Loosely correlated
+2.59%
EQ - MTNB
32%
Poorly correlated
-1.65%
More